Genome-editing technologies: Principles and applications

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 12, 2016, Pages

  Gaj, Thomas ^a   Sirk, Shannon J ^b   Shui, Sai Lan ^c   Liu, Jia ^c  

^a University of California at Berkeley   (United States)

^b Stanford University   (United States)

^c SHANGHAITECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE;

ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EDITING; HUMAN; METABOLISM;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; ENDONUCLEASES; GENE EDITING; HUMANS;

EID: 85006058313     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a023754     Document Type: Article

References (256)

1. Akbari OS, Bellen HJ, Bier E, Bullock SL, Burt A, Church GM, Cook KR, Duchek P, Edwards OR, Esvelt KM, et al. 2015. Safeguarding gene drive experiments in the laboratory. Science 349: 927-929
2. Akopian A, He J, Boocock MR, Stark WM. 2003. Chimeric recombinases with designed DNA sequence recognition. Proc Natl Acad Sci 100: 8688-8691
3. Anders C, Niewoehner O, Duerst A, Jinek M. 2014. Structural basis of PAM-dependent targetDNA recognition by the Cas9 endonuclease. Nature 513: 569-573
4. Anguela XM, Sharma R, Doyon Y, Miller JC, Li H, Haurigot V, Rohde ME, Wong SY, Davidson RJ, Zhou S, et al. 2013. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122: 3283-3287
5. Bae KH, Kwon YD, Shin HC, Hwang MS, Ryu EH, Park KS, Yang HY, Lee DK, Lee Y, Park J, et al. 2003. Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat Biotechnol 21: 275-280
6. Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T. 2015. Conditionally stabilized dCas9 activator for controlling gene expression in human cell reprogramming and differentiation. Stem Cell Rep 5: 448-459
7. Baltes NJ, Voytas DF. 2015. Enabling plant synthetic biology through genome engineering. Trends Biotechnol 33: 120-131
8. Beerli RR, Barbas CF III. 2002. Engineering polydactyl zincfinger transcription factors. Nat Biotechnol 20: 135-141
9. Beerli RR, Segal DJ, Dreier B, Barbas CF III 1998. Toward controlling gene expression at will: Specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci 95: 14628-14633
10. Beerli RR, Dreier B, Barbas CF III 2000a. Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci 97: 1495-1500
11. Beerli RR, Schopfer U, Dreier B, Barbas CF III 2000b. Chemically regulated zinc finger transcription factors. J Biol Chem 275: 32617-32627
12. Bhakta MS, Henry IM, Ousterout DG, Das KT, Lockwood SH, Meckler JF, Wallen MC, Zykovich A, Yu Y, Leo H, et al. 2013. Highly active zinc-finger nucleases by extended modular assembly. Genome Res 23: 530-538
13. Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, Chandrasegaran S. 2001. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21: 289-297
14. Bibikova M, Golic M, Golic KG, Carroll D. 2002. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics 161: 1169-1175
15. Bibikova M, Beumer K, Trautman JK, Carroll D. 2003. Enhancing gene targeting with designed zinc finger nucleases. Science 300: 764.
16. Blancafort P, Chen EI, Gonzalez B, Bergquist S, Zijlstra A, Guthy D, Brachat A, Brakenhoff RH, Quigley JP, Erdmann D, et al. 2005. Genetic reprogramming of tumor cells by zinc finger transcription factors. Proc Natl Acad Sci 102: 11716-11721
17. Blancafort P, Tschan MP, Bergquist S, Guthy D, Brachat A, Sheeter DA, Torbett BE, Erdmann D, Barbas CF III. 2008. Modulation of drug resistance by artificial transcription factors. Mol Cancer Ther 7: 688-697
18. Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326: 1509-1512
19. Boissel S, Jarjour J, Astrakhan A, Adey A, Gouble A, Duchateau P, Shendure J, Stoddard BL, Certo MT, Baker D, et al. 2014. megaTALs: A rare-cleaving nuclease architecture for therapeutic genome engineering. Nucleic Acids Res 42: 2591-2601
20. Bolukbasi MF, Gupta A, Oikemus S, Derr AG, Garber M, Brodsky MH, Zhu LJ, Wolfe SA. 2015. DNA-bindingdomain fusions enhance the targeting range and precision of Cas9. Nat Methods 12: 1150-1156
21. Briggs AW, Rios X, Chari R, Yang L, Zhang F, Mali P, Church GM. 2012. Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers. Nucleic Acids Res 40: e117.
22. Burt A. 2003. Site-specific selfish genes as tools for the control and genetic engineering of natural populations. Proc Biol Sci 270: 921-928
23. Cai Y, Bak RO, Mikkelsen JG. 2014. Targeted genome editing by lentiviral protein transduction of zinc-finger and TALeffector nucleases. eLife 3: e01911.
24. Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M, Voytas DF, Long CR, Whitelaw CB, Fahrenkrug SC. 2012. Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci 109: 17382-17387
25. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39: e82.
26. Chakraborty S, Ji H, Kabadi AM, Gersbach CA, Christoforou N, Leong KW. 2014. ACRISPR/Cas9-based system for reprogramming cell lineage specification. Stem Cell Rep 3: 940-947
27. Chavez A, Scheiman J, Vora S, Pruitt BW, Tuttle M, Iyer EPR, Lin S, Kiani S, Guzman CD, Wiegand DJ, et al. 2015. Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12: 326-328
28. Chen H, Kazemier HG, de Groote ML, Ruiters MH, Xu GL, Rots MG. 2014. Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res 42: 1563-1574
29. Chen S, Sanjana NE, Zheng K, Shalem O, Lee K, Shi X, Scott DA, Song J, Pan JQ, Weissleder R, et al. 2015. Genomewide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160: 1246-1260
30. Cho SW, Kim S, Kim JM, Kim JS. 2013. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-232
31. Choo Y, Klug A. 1994. Toward a code for the interactions of zinc fingers with DNA: Selection of randomized fingers displayed on phage. Proc Natl Acad Sci 91: 11163-11167
32. Choulika A, Perrin A, Dujon B, Nicolas JF. 1995. Induction of homologous recombination in mammalian chromo-somes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 15: 1968-1973
33. Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF. 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186: 757-761
34. Cong L, Zhou R, Kuo YC, Cunniff M, Zhang F. 2012. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 3: 968.
35. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823
36. Copeland MF, Politz MC, Johnson CB, Markley AL, Pfleger BF. 2016. A transcription activator-like effector (TALE) induction system mediated by proteolysis. Nat Chem Biol 12: 254-260
37. Cox DB, Platt RJ, Zhang F. 2015. Therapeutic genome editing: Prospects and challenges. Nat Med 21: 121-131
38. Cradick TJ, Fine EJ, Antico CJ, Bao G. 2013. CRISPR/Cas9 systems targeting b-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41: 9584-9592
39. Cui X, Ji D, Fisher DA, Wu Y, Briner DM, Weinstein EJ. 2011. Targeted integration in rat and mouse embryos with zincfinger nucleases. Nat Biotechnol 29: 64-67
40. Dahlman JE, Abudayyeh OO, Joung J, Gootenberg JS, Zhang F, Konermann S. 2015. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat Biotechnol 33: 1159-1161
41. Davis KM, Pattanayak V, Thompson DB, Zuris JA, Liu DR. 2015. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol 11: 316-318
42. Deng D, Yan C, Pan X, Mahfouz M, Wang J, Zhu JK, Shi Y, Yan N. 2012. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 335: 720-723
43. DiCarlo JE, Chavez A, Dietz SL, Esvelt KM, Church GM. 2015. Safeguarding CRISPR-Cas9 gene drives in yeast. Nat Biotechnol 33: 1250-1255
44. Doyon Y, McCammon JM, Miller JC, Faraji F, Ngo C, Katibah GE, Amora R, Hocking TD, Zhang L, Rebar EJ, et al. 2008. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol 26: 702-708
45. Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD, Holmes MC. 2011. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 8: 74-79
46. Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF III 2001. Development of zinc finger domains for recognition of the 50-ANN-30 family ofDNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276: 29466-29478
47. Dreier B, Fuller RP, Segal DJ, Lund CV, Blancafort P, Huber A, Koksch B, Barbas CF III 2005. Development of zinc finger domains for recognition of the 50-CNN-30 family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280: 35588-35597
48. Eberhardy SR, Goncalves J, Coelho S, Segal DJ, Berkhout B, Barbas CF III. 2006. Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J Virol 80: 2873-2883
49. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM. 2013. Orthogonal Cas9 proteins for RNAguided gene regulation and editing. Nat Methods 10: 1116-1121
50. Esvelt KM, Smidler AL, Catteruccia F, Church GM. 2014. Concerning RNA-guided gene drives for the alteration of wild populations. eLife doi: 10.7554/eLife.03401.
51. Farzadfard F, Perli SD, Lu TK. 2013. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth Biol 2: 604-613
52. Findlay GM, Boyle EA, Hause RJ, Klein JC, Shendure J. 2014. Saturation editing of genomic regions by multiplex homology-directed repair. Nature 513: 120-123
53. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31: 822-826
54. Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32: 279-284
55. Gaber R, Lebar T, Majerle A, Ster B, Dobnikar A, Bencina M, Jerala R. 2014. Designable DNA-binding domains enable construction of logic circuits in mammalian cells. Nat Chem Biol 10: 203-208
56. Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae CC, Wang J, Friedman G, et al. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29: 816-823
57. Gaj T, Guo J, Kato Y, Sirk SJ, Barbas CF III 2012. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods 9: 805-807
58. Gaj T, Mercer AC, Sirk SJ, Smith HL, Barbas CF III 2013. A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells. Nucleic Acids Res 41: 3937-3946
59. Gaj T, Liu J, Anderson KE, Sirk SJ, Barbas CF III 2014a. Protein delivery using Cys2-His2 zinc-finger domains. ACS Chem Biol 9: 1662-1667
60. Gaj T, Sirk SJ, Tingle RD, Mercer AC, Wallen MC, Barbas CF III 2014b. Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesign. J Am Chem Soc 136: 5047-5056
61. Gaj T, Epstein BE, Schaffer DV. 2016. Genome engineering using adeno-associated virus: Basic and clinical research applications. Mol Ther 24: 458-464
62. Gantz VM, Bier E. 2015. The mutagenic chain reaction: A method for converting heterozygous to homozygous mutations. Science 348: 442-444
63. Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E, James AA. 2015. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci 112: E6736-E6743
64. Gao X, Yang J, Tsang JC, Ooi J, Wu D, Liu P. 2013. Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers. Stem Cell Rep 1: 183-197
65. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, et al. 2009. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325: 433.
66. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ. 2014. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol 32: 819-821
67. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, et al. 2013. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154: 442-451
68. Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, et al. 2014. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159: 647-661
69. Graslund T, Li X, Magnenat L, Popkov M, Barbas CF III 2005. Exploring strategies for the design of artificial transcription factors: Targeting sites proximal to known regulatory regions for the induction of g-globin expression and the treatment of sickle cell disease. J Biol Chem 280: 3707-3714
70. Greisman HA, Pabo CO. 1997. A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites. Science 275: 657-661
71. Guilinger JP, Pattanayak V, Reyon D, Tsai SQ, Sander JD, Joung JK, Liu DR. 2014a. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods 11: 429-435
72. Guilinger JP, Thompson DB, Liu DR. 2014b. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32: 577-582
73. Guo J, Gaj T, Barbas CF III 2010. Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400: 96-107
74. Gupta A, Christensen RG, Rayla AL, Lakshmanan A, Stormo GD, Wolfe SA. 2012. An optimized two-finger archive for ZFN-mediated gene targeting. Nat Methods 9: 588-590
75. Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C, Katsanos D, Gribble M, Baker D, Marois E, Russell S, et al. 2016. ACRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotechnol 34: 78-83
76. Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, et al. 2015. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163: 1515-1526
77. Haun W, Coffman A, Clasen BM, Demorest ZL, Lowy A, Ray E, Retterath A, Stoddard T, Juillerat A, Cedrone F, et al. 2014. Improved soybean oil quality by targeted mutagenesis of the fatty acid desaturase 2 gene family. Plant Biotechnol J 12: 934-940
78. Hauschild J, Petersen B, Santiago Y, Queisser AL, Carnwath JW, Lucas-Hahn A, Zhang L, Meng X, Gregory PD, Schwinzer R, et al. 2011. Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci 108: 12013-12017
79. Heigwer F, Kerr G, Boutros M. 2014. E-CRISP: Fast CRISPR target site identification. Nat Methods 11: 122-123
80. Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, et al. 2015. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33: 985-989
81. Hilton IB, Gersbach CA. 2015. Enabling functional genomics with genome engineering. Genome Res 25: 1442-1455
82. Hilton IB, D’Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE. 2015. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33: 510-517
83. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, et al. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29: 731-734
84. Holkers M, Maggio I, Liu J, Janssen JM, Miselli F, Mussolino C, Recchia A, Cathomen T, Goncalves MA. 2013. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41: e63.
85. Holkers M, Maggio I, Henriques SF, Janssen JM, Cathomen T, Goncalves MA. 2014. Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods 11: 1051-1057
86. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, et al. 2010.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28: 839-847
87. Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-170
88. Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, Thomson JA. 2013. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci 110: 15644-15649
89. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, et al. 2013. DNAtargeting specificity ofRNA-guided Cas9 nucleases. Nat Biotechnol 31: 827-832
90. Hu J, Lei Y, Wong WK, Liu S, Lee KC, He X, You W, Zhou R, Guo JT, Chen X, et al. 2014. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res 42: 4375-4390
91. Hubbard BP, Badran AH, Zuris JA, Guilinger JP, Davis KM, Chen L, Tsai SQ, Sander JD, Joung JK, Liu DR. 2015. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. NatMethods 12: 939-942
92. Hurt JA, Thibodeau SA, Hirsh AS, Pabo CO, Joung JK. 2003. Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection. ProcNatl Acad Sci 100: 12271-12276
93. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31: 227-229
94. Isalan M, Klug A, Choo Y. 2001.A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 19: 656-660
95. Jakociunas T, Bonde I, Herrgard M, Harrison SJ, Kristensen M, Pedersen LE, Jensen MK, Keasling JD. 2015a. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab Eng 28: 213-222
96. Jakociunas T, Rajkumar AS, Zhang J, Arsovska D, Rodriguez A, Jendresen CB, Skjodt ML, Nielsen AT, Borodina I, Jensen MK, et al. 2015b. CasEMBLR: Cas9-facilitated multiloci genomic integration of in vivo assembled DNA parts in Saccharomyces cerevisiae. ACS Synth Biol 4: 1226-1234
97. Jamieson AC, Kim SH, Wells JA. 1994. In vitro selection of zinc fingers with altered DNA-binding specificity. Biochemistry 33: 5689-5695
98. Ji H, Jiang Z, Lu P, Ma L, Li C, Pan H, Fu Z, Qu X, Wang P, Deng J, et al. 2016. Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter. Mol Ther 24: 508-521
99. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPRCas systems. Nat Biotechnol 31: 233-239
100. Jiang F, Taylor DW, Chen JS, Kornfeld JE, Zhou K, Thompson AJ, Nogales E, Doudna JA. 2016. Structures of a CRISPR-Cas9 R-loop complex primed forDNAcleavage. Science 351: 867-871
101. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821
102. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. 2013. RNA-programmed genome editing in human cells. eLife 2: e00471.
103. Juillerat A, Pessereau C, Dubois G, Guyot V, Marechal A, Valton J, Daboussi F, Poirot L, Duclert A, Duchateau P. 2015. Optimized tuning of TALEN specificity using nonconventional RVDs. Sci Rep 5: 8150.
104. Kiani S, Chavez A, Tuttle M, Hall RN, Chari R, Ter-Ovanesyan D, Qian J, Pruitt BW, Beal J, Vora S, et al. 2015. Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods 12: 1051-1054
105. Kim YG, Cha J, Chandrasegaran S. 1996. Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci 93: 1156-1160
106. Kim HJ, Lee HJ, Kim H, Cho SW, Kim JS. 2009. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res 19: 1279-1288
107. Kim E, Kim S, Kim DH, Choi BS, Choi IY, Kim JS. 2012. Precision genome engineering with programmable DNA-nicking enzymes. Genome Res 22: 1327-1333
108. Kim Y, Kweon J, Kim A, Chon JK, Yoo JY, Kim HJ, Kim S, Lee C, Jeong E, Chung E, et al. 2013a.A library of TAL effector nucleases spanning the human genome. Nat Biotechnol 31: 251-258
109. Kim YK, Wee G, Park J, Kim J, Baek D, Kim JS, Kim VN. 2013b. TALEN-based knockout library for human micro-RNAs. Nat Struct Mol Biol 20: 1458-1464
110. Kim S, Kim D, Cho SW, Kim J, Kim JS. 2014. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24: 1012-1019
111. Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JR, et al. 2015. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523: 481-485
112. Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK. 2016. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529: 490-495
113. Koike-Yusa H, Li Y, Tan EP, Velasco-HerreraMdel C, Yusa K. 2014. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32: 267-273
114. Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. 2016. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature doi: 10.1038/nature17946.
115. Konermann S, Brigham MD, Trevino AE, Hsu PD, Heidenreich M, Cong L, Platt RJ, Scott DA, Church GM, Zhang F. 2013. Optical control of mammalian endogenous transcription and epigenetic states. Nature 500: 472-476
116. Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, et al. 2015. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517: 583-588
117. Korkmaz G, Lopes R, Ugalde AP, Nevedomskaya E, Han R, Myacheva K, Zwart W, Elkon R, Agami R. 2016. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat Biotechnol 34: 192-198
118. Lebar T, Bezeljak U, Golob A, Jerala M, Kadunc L, Pirs B, Strazar M, Vucko D, Zupancic U, Bencina M, et al. 2014. A bistable genetic switch based on designableDNA-binding domains. Nat Commun 5: 5007.
119. Lee HJ, Kim E, Kim JS. 2010. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res 20: 81-89
120. Li H, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, Malani N, Anguela XM, Sharma R, Ivanciu L, et al. 2011. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475: 217-221
121. Li Y, Moore R, Guinn M, Bleris L. 2012. Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci Rep 2: 897.
122. Li W, Teng F, Li T, Zhou Q. 2013. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 31: 684-686
123. Limsirichai P, Gaj T, Schaffer DV. 2016. CRISPR-mediated activation of latent HIV-1 expression. Mol Ther 24: 499-507
124. Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, Lin YY, Wang HY, Wang CC, Shen YC, et al. 2014. The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids 3: e186.
125. Lin J, Chen H, Luo L, Lai Y, Xie W, Kee K. 2015a. Creating a monomeric endonuclease TALE-I-SceI with high specificity and low genotoxicity in human cells. Nucleic Acids Res 43: 1112-1122
126. Lin S, Ewen-Campen B, Ni X, Housden BE, Perrimon N. 2015b. In vivo transcriptional activation using CRISPR/Cas9 in Drosophila. Genetics 201: 433-442
127. Liu Q, Segal DJ, Ghiara JB, Barbas CF III. 1997. Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci 94: 5525-5530
128. Liu J, Gaj T, Patterson JT, Sirk SJ, Barbas CF III. 2014a. Cellpenetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS ONE 9: e85755.
129. Liu Y, Zeng Y, Liu L, Zhuang C, Fu X, Huang W, Cai Z. 2014b. Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells. Nat Commun 5: 5393.
130. Liu Z, Zhou X, Zhu Y, Chen ZF, Yu B, Wang Y, Zhang CC, Nie YH, Sang X, Cai YJ, et al. 2014c. Generation of a monkey with MECP2 mutations by TALEN-based gene targeting. Neurosci Bull 30: 381-386
131. Liu J, Gaj T, Wallen MC, Barbas CF III 2015a. Improved cellpenetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids 4: e232.
132. Liu J, Gaj T, Yang Y, Wang N, Shui S, Kim S, Kanchiswamy CN, Kim JS, Barbas CF III 2015b. Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells. Nat Protoc 10: 1842-1859
133. Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN. 2015. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351: 400-403
134. Lonzaric J, Lebar T, Majerle A, Mancek-Keber M, Jerala R. 2016. Locked and proteolysis-based transcription activator-like effector (TALE) regulation. Nucleic Acids Res 44: 1471-1481
135. Luo S, Li J, Stoddard TJ, Baltes NJ, Demorest ZL, Clasen BM, Coffman A, Retterath A, Mathis L, Voytas DF, et al. 2015. Non-transgenic plant genome editing using purified sequence-specific nucleases. Mol Plant 8: 1425-1427
136. Ma H, Dang Y, Wu Y, Jia G, Anaya E, Zhang J, Abraham S, Choi JG, Shi G, Qi L, et al. 2015. ACRISPR-based screen identifies genes essential for West-Nile-virus-induced cell death. Cell Rep 12: 673-683
137. Maeder ML, Gersbach CA. 2016. Genome-editing technologies for gene and cell therapy. Mol Ther 24: 430-446
138. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, et al. 2008. Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31: 294-301
139. Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. 2013a. CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10: 977-979
140. Maeder ML, Linder SJ, Reyon D, Angstman JF, Fu Y, Sander JD, Joung JK. 2013b. Robust, synergistic regulation of human gene expression using TALE activators. NatMethods 10: 243-245
141. Maggio I, Stefanucci L, Janssen JM, Liu J, Chen X, Mouly V, Goncalves MA. 2016. Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations. Nucleic Acids Res 44: 1449-1470
142. Magnenat L, Blancafort P, Barbas CF III 2004. In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation. J Mol Biol 341: 635-649
143. Magnenat L, Schwimmer LJ, Barbas CF III 2008. Druginducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther 15: 1223-1232
144. Mahiny AJ, Dewerth A, Mays LE, Alkhaled M, Mothes B, Malaeksefat E, Loretz B, Rottenberger J, Brosch DM, Reautschnig P, et al. 2015. In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency. Nat Biotechnol 33: 584-586
145. Mak AN, Bradley P, Cernadas RA, Bogdanove AJ, Stoddard BL. 2012. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335: 716-719
146. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM. 2013a. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31: 833-838
147. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. 2013b. RNA-guided human genome engineering via Cas9. Science 339: 823-826
148. Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ III 1994. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci 91: 4509-4513
149. Marraffini LA, Sontheimer EJ. 2010. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11: 181-190
150. McConnell Smith A, Takeuchi R, Pellenz S, Davis L, Maizels N, Monnat RJ Jr, Stoddard BL. 2009. Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease. Proc Natl Acad Sci 106: 5099-5104
151. Meckler JF, Bhakta MS, Kim MS, Ovadia R, Habrian CH, Zykovich A, Yu A, Lockwood SH, Morbitzer R, Elsaesser J, et al. 2013. Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res 41: 4118-4128
152. Mendenhall EM, Williamson KE, Reyon D, Zou JY, Ram O, Joung JK, Bernstein BE. 2013. Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 31: 1133-1136
153. Menoret S, De Cian A, Tesson L, Remy S, Usal C, Boule JB, Boix C, Fontaniere S, Creneguy A, Nguyen TH, et al. 2015. Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins. Sci Rep 5: 14410.
154. Mercer AC, Gaj T, Fuller RP, Barbas CF III. 2012. Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res 40: 11163-11172
155. Mercer AC, Gaj T, Sirk SJ, Lamb BM, Barbas CF III 2014. Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth Biol 3: 723-730
156. Miller JC, Holmes MC, Wang J, Guschin DY, Lee YL, Rupniewski I, Beausejour CM, Waite AJ, Wang NS, Kim KA, et al. 2007. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25: 778-785
157. Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ, et al. 2011. ATALE nuclease architecture for efficient genome editing. Nat Biotechnol 29: 143-148
158. Miller JC, Zhang L, Xia DF, Campo JJ, Ankoudinova IV, Guschin DY, Babiarz JE, Meng X, Hinkley SJ, Lam SC, et al. 2015. Improved specificity of TALE-based genome editing using an expanded RVD repertoire. Nat Methods 12: 465-471
159. Mock U, Machowicz R, Hauber I, Horn S, Abramowski P, Berdien B, Hauber J, Fehse B. 2015. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res 43: 5560-5571
160. Moehle EA, Rock JM, Lee YL, Jouvenot Y, DeKelver RC, Gregory PD, Urnov FD, Holmes MC. 2007. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci 104: 3055-3060
161. Moscou MJ, Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326: 1501.
162. Mussolino C, Alzubi J, Fine EJ, Morbitzer R, Cradick TJ, Lahaye T, Bao G, Cathomen T. 2014. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res 42: 6762-6773
163. Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Rivera RMC, Madhavan S, Pan X, Ran FA, Yan WX, et al. 2015. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351: 403-407
164. Nielsen AA, Voigt CA. 2014. Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol Syst Biol 10: 763.
165. Nihongaki Y, Yamamoto S, Kawano F, Suzuki H, Sato M. 2015. CRISPR-Cas9-based photoactivatable transcription system. Chem Biol 22: 169-174
166. Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, Ishitani R, Zhang F, Nureki O. 2014. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156: 935-949
167. Nissim L, Perli SD, Fridkin A, Perez-Pinera P, Lu TK. 2014. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell 54: 698-710
168. Osborn MJ, Webber BR, Knipping F, Lonetree CL, Tennis N, DeFeo AP, McElroy AN, Starker CG, Lee C, Merkel S, et al. 2016. Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases. Mol Ther 24: 570-581
169. Paix A, Folkmann A, Rasoloson D, Seydoux G. 2015. High efficiency, homology-directed genome editing in Caenorhabditis elegans using CRISPR-Cas9 ribonucleoprotein complexes. Genetics 201: 47-54
170. Papworth M, Moore M, Isalan M, Minczuk M, Choo Y, Klug A. 2003. Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc Natl Acad Sci 100: 1621-1626
171. Park KS, Lee DK, Lee H, Lee Y, Jang YS, Kim YH, Yang HY, Lee SI, Seol W, Kim JS. 2003. Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors. Nat Biotechnol 21: 1208-1214
172. Parnas O, Jovanovic M, Eisenhaure TM, Herbst RH, Dixit A, Ye CJ, Przybylski D, Platt RJ, Tirosh I, Sanjana NE, et al. 2015. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162: 675-686
173. Pattanayak V, Ramirez CL, Joung JK, Liu DR. 2011. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 8: 765-770
174. Pavletich NP, Pabo CO. 1991. Zinc finger-DNA recognition: Crystal structure of a Zif268-DNA complex at 2.1 A. Science 252: 809-817
175. Perdigao P, Gaj T, Santa-Marta M, Barbas CF III, Goncalves J. 2016. Reactivation of latent HIV-1 expression by engineered TALE transcription factors. PLoS ONE 11: e0150037.
176. Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, et al. 2008. Establishment of HIV-1 resistance in CD4þ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816
177. Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ, Gersbach CA. 2013. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods 10: 239-242
178. Piatek A, Ali Z, Baazim H, Li L, Abulfaraj A, Al-Shareef S, Aouida M, Mahfouz MM. 2015. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol J 13: 578-589
179. Pollock R, Giel M, Linher K, Clackson T. 2002. Regulation of endogenous gene expression with a small-molecule dimerizer. Nat Biotechnol 20: 729-733
180. Polstein LR, Gersbach CA. 2012. Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J Am Chem Soc 134: 16480-16483
181. Polstein LR, Gersbach CA. 2015. A light-inducible CRISPRCas9 system for control of endogenous gene activation. Nat Chem Biol 11: 198-200
182. Porteus MH. 2015. Towards a new era in medicine: Therapeutic genome editing. Genome Biol 16: 286.
183. Porteus MH, Baltimore D. 2003. Chimeric nucleases stimulate gene targeting in human cells. Science 300: 763.
184. Porteus MH, Carroll D. 2005. Gene targeting using zinc finger nucleases. Nat Biotechnol 23: 967-973
185. Pruett-Miller SM, Reading DW, Porter SN, Porteus MH. 2009. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet 5: e1000376.
186. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152: 1173-1183
187. Rahdar M, McMahon MA, Prakash TP, Swayze EE, Bennett CF, Cleveland DW. 2015. Synthetic CRISPR RNA-Cas9-guided genome editing in human cells. ProcNatl Acad Sci 112: E7110-E7117
188. Ramirez CL, Certo MT, Mussolino C, Goodwin MJ, Cradick TJ, McCaffrey AP, Cathomen T, Scharenberg AM, Joung JK. 2012. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res 40: 5560-5568
189. Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, et al. 2013. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-1389
190. Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, et al. 2015. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520: 186-191
191. Rebar EJ, Huang Y, Hickey R, Nath AK, Meoli D, Nath S, Chen B, Xu L, Liang Y, Jamieson AC, et al. 2002. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 8: 1427-1432
192. Reynolds L, Ullman C, Moore M, Isalan M, West MJ, Clapham P, Klug A, Choo Y. 2003. Repression of the HIV-1 50 LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci 100: 1615-1620
193. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. 2012. FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol 30: 460-465
194. Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, Blancafort P. 2012. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7: 350-360
195. Rouet P, Smih F, Jasin M. 1994. Introduction of doublestrand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol 14: 8096-8106
196. Ryan OW, Skerker JM, Maurer MJ, Li X, Tsai JC, Poddar S, Lee ME, DeLoache W, Dueber JE, Arkin AP, et al. 2014. Selection of chromosomal DNA libraries using a multiplex CRISPR system. eLife doi: 10.7554/eLife.03703.
197. Saayman SM, Lazar DC, Scott TA, Hart JR, Takahashi M, Burnett JC, Planelles V, Morris KV, Weinberg MS. 2016. Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex. Mol Ther 24: 488-498
198. Sadowski I, Ma J, Triezenberg S, Ptashne M. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335: 563-564
199. Sander JD, Cade L, Khayter C, Reyon D, Peterson RT, Joung JK, Yeh JR. 2011a. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol 29: 697-698
200. Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, et al. 2011b. Selection-free zinc-fingernuclease engineering by context-dependent assembly (CoDA). Nat Methods 8: 67-69
201. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, Urnov FD, Holmes MC, Guschin D, Waite A, Miller JC, et al. 2008. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci 105: 5809-5814
202. Sather BD, Romano Ibarra GS, Sommer K, Curinga G, Hale M, Khan IF, Singh S, Song Y, Gwiazda K, Sahni J, et al. 2015. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sci Transl Med 7: 307ra156.
203. Schmid-Burgk JL, Schmidt T, Kaiser V, Honing K, Hornung V. 2013. A ligation-independent cloning technique for high-throughput assembly of transcription activatorlike effector genes. Nat Biotechnol 31: 76-81
204. Schumann K, Lin S, Boyer E, Simeonov DR, Subramaniam M, Gate RE, Haliburton GE, Ye CJ, Bluestone JA, Doudna JA, et al. 2015. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci 112: 10437-10442
205. Segal DJ, Dreier B, Beerli RR, Barbas CF III 1999. Toward controlling gene expression at will: Selection and design of zinc finger domains recognizing each of the 50-GNN-30 DNAtarget sequences. ProcNatl Acad Sci 96: 2758-2763
206. Segal DJ, Goncalves J, Eberhardy S, Swan CH, Torbett BE, Li X, Barbas CF III 2004. Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J Biol Chem 279: 14509-14519
207. Shah AN, Davey CF, Whitebirch AC, Miller AC, Moens CB. 2015. Rapid reverse genetic screening using CRISPR in zebrafish. Nat Methods 12: 535-540
208. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, et al. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343: 84-87
209. Sharma R, Anguela XM, Doyon Y, Wechsler T, DeKelver RC, Sproul S, Paschon DE, Miller JC, Davidson RJ, Shivak D, et al. 2015. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126: 1777-1784
210. Siddique AN, Nunna S, Rajavelu A, Zhang Y, Jurkowska RZ, Reinhardt R, Rots MG, Ragozin S, Jurkowski TP, Jeltsch A. 2013. Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. J Mol Biol 425: 479-491
211. Silva G, Poirot L, Galetto R, Smith J, Montoya G, Duchateau P, Paques F. 2011. Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy. Curr Gene Ther 11: 11-27
212. Sinkins SP, Gould F. 2006. Gene drive systems for insect disease vectors. Nat Rev Genet 7: 427-435
213. Sirk SJ, Gaj T, Jonsson A, Mercer AC, Barbas CF III 2014. Expanding the zinc-finger recombinase repertoire: Directed evolution and mutational analysis of serine recombinase specificity determinants. Nucleic Acids Res 42: 4755-4766
214. Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. 2016. Rationally engineered Cas9 nucleases with improved specificity. Science 351: 84-88
215. Smith J, Bibikova M, Whitby FG, Reddy AR, Chandrasegaran S, Carroll D. 2000. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res 28: 3361-3369
216. Sorek R, Lawrence CM, Wiedenheft B. 2013. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 82: 237-266
217. Stoddard BL. 2011.Homing endonucleases: Frommicrobial genetic invaders to reagents for targeted DNA modification. Structure 19: 7-15
218. Stoddard BL. 2014. Homing endonucleases from mobile group I introns: Discovery to genome engineering. Mob DNA 5: 7.
219. Streubel J, Blucher C, Landgraf A, Boch J. 2012. TAL effector RVD specificities and efficiencies. Nat Biotechnol 30: 593-595
220. Sung YH, Kim JM, Kim HT, Lee J, Jeon J, Jin Y, Choi JH, Ban YH, Ha SJ, Kim CH, et al. 2014. Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res 24: 125-131
221. Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, et al. 2015. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351: 407-411
222. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, et al. 2014. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370: 901-910
223. Tesson L, Usal C, Menoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L, et al. 2011. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29: 695-696
224. Thakore PI, D’Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, Reddy TE, Crawford GE, Gersbach CA. 2015. Highly specific epigenome editing by CRISPRCas9 repressors for silencing of distal regulatory elements. Nat Methods 12: 1143-1149
225. Tong Y, Charusanti P, Zhang L, Weber T, Lee SY. 2015. CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth Biol 4: 1020-1029
226. Torres R, Martin MC, Garcia A, Cigudosa JC, Ramirez JC, Rodriguez-Perales S. 2014. Engineering human tumourassociated chromosomal translocations with the RNAguided CRISPR-Cas9 system. Nat Commun 5: 3964.
227. Tsai SQ, Wyvekens N, Khayter C, Foden JA, Thapar V, Reyon D, Goodwin MJ, Aryee MJ, Joung JK. 2014. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32: 569-576
228. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-651
229. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. 2010. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11: 636-646
230. Wallen MC, Gaj T, Barbas CF III 2015. Redesigning recombinase specificity for safe harbor sites in the human genome. PLoS ONE 10: e0139123.
231. Wang J, Friedman G, Doyon Y, Wang NS, Li CJ, Miller JC, Hua KL, Yan JJ, Babiarz JE, Gregory PD, et al. 2012. Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res 22: 1316-1326
232. Wang H, Hu YC, Markoulaki S, Welstead GG, Cheng AW, Shivalila CS, Pyntikova T, Dadon DB, Voytas DF, Bogdanove AJ, et al. 2013. TALEN-mediated editing of the mouse Y chromosome. Nat Biotechnol 31: 530-532
233. Wang T, Wei JJ, Sabatini DM, Lander ES. 2014a. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343: 80-84
234. Wang Y, Cheng X, Shan Q, Zhang Y, Liu J, Gao C, Qiu JL. 2014b. Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew. Nat Biotechnol 32: 947-951
235. Wang L, Shao Y, Guan Y, Li L, Wu L, Chen F, Liu M, Chen H, Ma Y, Ma X, et al. 2015a. Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep 5: 17517.
236. Wang T, Birsoy K, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM. 2015b. Identification and characterization of essential genes in the human genome. Science 350: 1096-1101
237. Wiedenheft B, Sternberg SH, Doudna JA. 2012. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-338
238. Wilber A, Tschulena U, Hargrove PW, Kim YS, Persons DA, Barbas CF III, Nienhuis AW. 2010. A zinc-finger transcriptional activator designed to interact with the g-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Blood 115: 3033-3041
239. Windbichler N, Menichelli M, Papathanos PA, Thyme SB, Li H, Ulge UY, Hovde BT, Baker D, Monnat RJ Jr, Burt A, et al. 2011. A synthetic homing endonuclease-based gene drive system in the human malaria mosquito.Nature 473: 212-215
240. Wolfe SA, Nekludova L, Pabo CO. 2000.DNArecognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct 29: 183-212
241. Woo JW, Kim J, Kwon SI, Corvalan C, Cho SW, Kim H, Kim SG, Kim ST, Choe S, Kim JS. 2015. DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins. Nat Biotechnol 33: 1162-1164
242. Wu H, Yang WP, Barbas CF III 1995. Building zinc fingers by selection: Toward a therapeutic application. Proc Natl Acad Sci 92: 344-348
243. Wu Y, Liang D, Wang Y, Bai M, Tang W, Bao S, Yan Z, Li D, Li J. 2013.Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13: 659-662
244. Wu H, Wang Y, Zhang Y, Yang M, Lv J, Liu J, Zhang Y. 2015. TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proc Natl Acad Sci 112: E1530-E1539
245. Xiao A, Wang Z, Hu Y, Wu Y, Luo Z, Yang Z, Zu Y, Li W, Huang P, Tong X, et al. 2013. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res 41: e141.
246. Yang J, Zhang Y, Yuan P, Zhou Y, Cai C, Ren Q, Wen D, Chu C, Qi H, Wei W. 2014. Complete decoding of TAL effectors for DNA recognition. Cell Res 24: 628-631
247. Yang Y, Wang L, Bell P, McMenamin D, He Z, White J, Yu H, Xu C, Morizono H, Musunuru K, et al. 2016. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol 34: 334-338
248. Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG. 2014. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol 32: 551-553
249. Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A, et al. 2016. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34: 328-333
250. Zalatan JG, Lee ME, Almeida R, Gilbert LA, Whitehead EH, La Russa M, Tsai JC, Weissman JS, Dueber JE, Qi LS, et al. 2015. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160: 339-350
251. Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, et al. 2015a. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163: 759-771
252. Zetsche B, Volz SE, Zhang F. 2015b. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33: 139-142
253. Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. 2011. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29: 149-153
254. Zhang Y, Yin C, Zhang T, Li F, Yang W, Kaminski R, Fagan PR, Putatunda R, Young WB, Khalili K, et al. 2015. CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs. Sci Rep 5: 16277.
255. Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y, Wei W. 2014. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509: 487-491
256. Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR. 2015. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol 33: 73-80